Bacterial signals can sustain immune protection after further antigen recognition stops
In older-donor cultures, bacterial ribonucleic acid (RNA) signals to antigen-presenting cells (APCs) would sustain timely killing and functional antibody production after initial recognition. Rescue after further antigen signaling stops would distinguish instruction from continued antigen availability.
Omega Point 1.2
Stage of verification
- Hypothesis published2026-09-21
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Immune cell
Antigen-presenting cells
Immune cells that present antigen and provide signals guiding adaptive immune responses
Where this hypothesis actsOlder-donor cultures after initial cognate priming and the first matched T–B interaction
Hypotheses on this target 1
Activation1
Clearance restoration
Reprogramming
Adoptive transfer
Elimination
Immunosuppression
Population balance
What is proposed
Activation
Deliver non-antigen-encoding bacterial RNA selectively to antigen-presenting cells
With whatTargeted delivery
HowAPC-targeted delivery of nonreplicating bacterial RNA to sustain the transient cytokine program after further cognate signaling is terminated
Possible result
Possible restoration of timely antigen-specific killing and functional antibody production
From the recordNon-antigen-encoding bacterial RNA delivered selectively to APCs restores the onset of antigen-specific target killing and functional antibody production despite absent subsequent cognate signaling.
Signalling pathway
Antigen-receptor signaling
Signaling through antigen receptors during cognate antigen recognition
Where this hypothesis actsOlder-donor cultures after documented cognate priming and matched T–B interaction
Hypotheses on this target 4
Inhibition1- Activation
Desensitisation
Function preservation
Feedback restoration
Rhythm restoration1
What is proposed
Terminate subsequent cognate antigen-receptor signaling
With whatChange of environment or regimen
HowTimed antigen withdrawal and independently validated receptor-blocking interventions, with effective termination verified without injuring lymphocytes
Possible result
Possible continued adaptive differentiation with RNA stimulation despite absent subsequent cognate signaling
From the recordthen terminate further antigen-receptor signaling using independently validated interventions.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Killing bacteria faster might leave the body's slower, targeted defenses less prepared. The unexpected move is to replace a signal associated with living bacteria rather than extend how long their recognizable material remains available. This is a pipeline-generated proposal, not a measured result: it predicts that bacterial RNA can sustain the development of protection even after further target recognition has been stopped.
- Initial target recognition and a first matched interaction between T and B cells start the targeted response.
- Accelerated bacterial killing is proposed to remove RNA signals associated with microbial life.
- Loss of those signals is proposed to interrupt the antigen-presenting cells' temporary production of instructive chemical messages.
- After initial recognition, continued development is proposed to depend on those messages rather than on repeated target recognition.
- Replacement bacterial RNA directed to antigen-presenting cells is proposed to maintain that instruction even when further target recognition is experimentally stopped.
- The maintained instruction is predicted to restore timely target killing and new functional antibody production; extending antigen availability alone is predicted to fail.
A work crew has received its assignment, but still needs a coordinator to keep the job moving. The proposal is that keeping the coordinator active can finish the job after the assignment notices are taken away.
Where the picture breaks: Immune cells do not necessarily receive a complete assignment at one encounter, and different cells may still require repeated recognition. Whether an ongoing chemical instruction can replace that recognition is precisely what remains unestablished.
- Master questionstep 01 of 04
Restoring immunity in older people means bringing both innate immunity, the body's rapid defenses, and adaptive immunity, its target-specific defenses, into healthy young-adult ranges for a lasting period. That restoration must preserve immunological memory, protection retained from earlier encounters; self-tolerance, avoidance of attacks on the body's own tissues; and control of latent infections, infections that persist without continuous active disease.
Rests on: The goal defines success as durable recovery of several functions together, with existing protections preserved. It does not establish that this combination is achievable.
Stated in the chain - Goal pillarstep 02 of 04
Reliable protection requires a handoff from recognizing a threat, through antigen presentation, the display of recognizable target material to immune cells, to cells that carry out a protective response.
Rests on: The master goal requires both rapid and target-specific defenses to function. The pillar identifies their handoff as the part of that goal pursued here, but supplies no further mechanism.
Stated in the chain - Gap questionstep 03 of 04
Faster bacterial killing might shorten the availability of antigen, material recognized by target-specific immune cells, enough to delay protection. Keeping that material available independently of living bacteria might prevent the delay without allowing surviving bacteria to escape control.
Rests on: The preceding pillar identifies the handoff between defenses as a concern, but does not explain how faster killing would disrupt it.
LeapNeither the preceding text nor the supplied source summaries establishes that accelerated killing shortens usable antigen availability enough to delay protection, or that independently preserving antigen prevents that delay.
- Hypothesisstep 04 of 04
Loss of bacterial life signals is proposed to cause the delay after faster killing. Once matching immune cells have first recognized their target and a matched T cell and B cell have interacted—the former helping direct the response and the latter capable of making antibodies—bacterial RNA is proposed to sustain further development even when subsequent target recognition stops. The proposed intermediary is a temporary program of cytokines, chemical messages between cells, produced by antigen-presenting cells, cells that display target material and help instruct other immune cells.S1S2S3
Rests on: The gap supplies the comparison between preserving antigen and preserving another instruction. Immunity (2018, S1) reports improved helper-cell and antibody responses when bacterial RNA supplemented a dead vaccine in mice, but does not test development after target recognition stops. Frontiers in Immunology (2017, S2) reports inflammatory message production in mouse immune cells exposed to bacterial RNA, but does not establish sustained instruction or restored protection. The supplied Nature Immunology abstract (2018, S3) reports that antigen-presenting cells distinguish living from dead bacteria through RNA detection, but does not test the proposed independence from further target recognition.
Supported by literature
What is carried, and what is not. The screened literature supports components of two links: bacterial RNA can trigger immune-cell signaling, and RNA supplementation can enhance some helper-cell and antibody responses. None of the supplied evidence establishes the complete sequence from accelerated killing through lost instruction to restoration of both protective functions after further target recognition has been stopped.
Where the reasoning is carried by something unstated · 1
- Gap question. Neither the preceding text nor the supplied source summaries establishes that accelerated killing shortens usable antigen availability enough to delay protection, or that independently preserving antigen prevents that delay. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Apparent rescue could depend on residual target recognition rather than independence from it; apparent failure could instead reflect injury caused by the intervention that blocks recognition. What closes it: The design requires independently validated ways to stop further antigen-receptor signaling, the signal generated when an immune cell's recognition receptor encounters its target. Termination must be verified throughout the relevant interval, alongside evidence that the affected cells remain alive and functionally capable.
- More immune cells, more chemical messages, or antibody already being secreted could be mistaken for newly developed protection. That would also obscure the rival explanation that some responding cells simply lacked enough time to complete their first recognition encounters. What closes it: Document initial recognition and the first matched T–B interaction in the responding cells being followed. As specified, distinguish newly recruited cell families and newly synthesized antibodies from pre-existing memory output, and measure target-specific killing and antibody function. The timing criteria for rescue must be fixed before the run; the supplied material gives no numerical deadlines.
- An RNA rescue could be credited to replacement of a missing instruction even if it instead counteracts the rival's proposed suppressive signal: prostaglandin E2, a signaling molecule released during the clearance of dying bacteria-engulfing cells. What closes it: Distinguishing those explanations requires measuring the proposed instructive messages alongside cell death, corpse clearance, and prostaglandin E2, with a comparison that separately reduces the suppressive route while maintaining bacterial killing. The supplied design does not specify that comparison, so RNA rescue alone would not identify which route caused the original delay.
What would make this wrong. The strong hypothesis would fail if, after verified initial recognition and matched T–B interaction, effective termination of further recognition without cell injury, and verified RNA delivery and sensing, replacement RNA did not restore timely target-specific killing and new functional antibody production. Rescue limited to cell multiplication, nonspecific chemical-message release, or pre-existing antibody secretion would also fail its stated prediction. Restoration of both functions by antigen extension alone, without the proposed RNA-dependent instruction, would contradict its claim that this instruction is required.
What it would change. If the proposal held, restoring aging immune defenses would require attention to the instructions left behind after rapid bacterial killing, as well as to killing itself and the duration of target availability. Preserving recognizable material alone would not reliably preserve the handoff to timely protection in the tested setting. Even a successful result in cultures made from older donors' own cells would not establish durable restoration in people, attainment of healthy young-adult ranges, preservation of memory and self-tolerance, or control of latent infections.
Sources read · 10
Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses. · Immunity · 2018
“Complementing the dead vaccine with an innate signature of bacterial viability, bacterial RNA, recapitulated these responses.”
Does not settle: This mouse vaccination study supports bacterial RNA-dependent enhancement of Tfh, germinal-center, and antibody responses, but does not test experimental termination or preservation of cognate antigen signaling, accelerated killing, CD8-effector differentiation, antibody-secreting-cell differentiation after antigen recognition stops, or sustained APC cytokine programs over time.
TLR7 and TLR3 Sense Brucella abortus RNA to Induce Proinflammatory Cytokine Production but They Are Dispensable for Host Control of Infection. · Frontiers in immunology · 2017
“B. abortus RNA function as an immunostimulatory PAMP that induces the production of proinflammatory cytokines in bone marrow-derived DCs.”
Does not settle: This source does not test antigen termination, accelerated killing, APC persistence of RNA sensing, CD4-helper or CD8-effector differentiation, antibody-secreting-cell differentiation, timely protection, or whether RNA stimulation restores protection. Its cytokine findings are in murine bone marrow-derived DCs.
Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses. · Nature immunology · 2018
“Antigen-presenting cells (APCs) distinguished viable bacteria from dead bacteria through Toll-like receptor 8 (TLR8)-dependent detection of bacterial RNA.”
Does not settle: It does not test experimentally terminating subsequent cognate antigen signaling, preserving antigen independently of viability signals, CD8-effector or antibody-secreting-cell differentiation, accelerated killing, or whether bacterial RNA sustains already specified differentiation after antigen recognition stops.
Bacterial transfer-messenger RNA activates antiviral RNA sensing to induce inflammatory innate immune responses. · Journal of immunology (Baltimore, Md. : 1950) · 2026
“tmRNA robustly induced the production of IL-6, TNF-α, and IFN-α in murine Flt3 ligand-derived dendritic cells.”
Does not settle: It does not test antigen termination, microbial viability, accelerated killing, APC cytokine-program maintenance over time, CD4/CD8 or antibody-secreting-cell differentiation, restoration of protection, or humans.
Human B cells. · Clinical and experimental immunology · 2022
“the role of antigen availability and its effect on B-cell memory and antibody production.”
Does not settle: It does not establish effects of bacterial RNA or microbial viability signals, antigen termination, APC cytokines, CD4 or CD8 differentiation, antibody-secreting-cell differentiation, protection timing, or any causal comparison of preserved antigen versus RNA stimulation.
Evolution of antibody immunity to SARS-CoV-2. · Nature · 2021
“Persistent antibody evolution occurs in germinal centres and requires that B cells are exposed to antigen trapped in the form of immune complexes on follicular dendritic cells .”
Does not settle: This source does not test bacterial viability signals or APC sensing of bacterial RNA, experimentally terminate cognate antigen signaling, or establish sustained CD4-helper, CD8-effector, or antibody-secreting-cell differentiation through an APC cytokine program.
“Overall, our results suggest that the type I IFN response after RRV infection limits dendritic cell (DC) infection, direct antigen presentation, and rapid induction of effector antiviral CD8 + T cells.”
Does not settle: This mouse RRV study does not test bacterial RNA, accelerated bacterial killing, experimental termination of cognate antigen signaling, antigen preservation, restoration by nonreplicating RNA stimulation, APC cytokine programs, CD4-helper differentiation, or antibody-secreting-cell differentiation.
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer. · Nature · 2021
“stimulation of these HPV-specific stem-like CD8 T cells with the cognate HPV peptide resulted in marked upregulation of TIM-3, granzyme B and CD39 by the tetramer-positive proliferating CD8 T cells”
Does not settle: This source does not test bacterial RNA, APC cytokine programs, antigen withdrawal, microbial viability signals, CD4-helper or antibody-secreting-cell differentiation, or whether differentiation continues after cognate antigen signaling is terminated.
Measuring Innate Immune Responses to Bacterial Viability. · Methods in molecular biology (Clifton, N.J.) · 2018
“The innate immune system directly senses microbial viability via the detection of a special class of viability-associated pathogen-associated molecular patterns (vita-PAMPs), such as prokaryotic messenger RNA.”
Does not settle: This abstract does not establish that bacterial RNA sustains specified CD4-helper, CD8-effector, or antibody-secreting-cell differentiation after cognate antigen signaling is terminated; it does not test antigen preservation, nonreplicating RNA rescue, protection timing, or an APC cytokine program as the causal substrate.
Exploiting vita-PAMPs in vaccines. · Current opinion in pharmacology · 2018
“A comparison of three E. coli vaccines in mice – live, dead and a vita -PAMP-supplemented dead vaccine ( vita -vaccine) – showed that only the live and vita vaccines induced a T FH response [ ].”
Does not settle: This source does not establish that bacterial RNA sustains differentiation after cognate antigen signaling has been experimentally terminated, that antigen persistence independently fails, or effects on CD8 effectors. Its described adaptive evidence centers on T FH cells and antibody-associated responses in vaccine and co-culture settings.
The gap this hypothesis explains
Can faster early pathogen killing delay learned immune protection, and can preserving recognizable pathogen material prevent this without infectious escape?
Original wording · exactly as the pipeline generated it
Can accelerating innate killing shorten antigen availability enough to delay adaptive protection, and does independently preserving presentable antigen prevent this reversal without permitting viable-pathogen escape?
What this question is asking
The question asks whether making the body's early immune response kill disease-causing organisms faster could slow the development of its learned protection. It asks whether faster killing removes recognizable pathogen material, called antigen, so quickly that the adaptive immune response has insufficient opportunity to develop protection. It then asks whether keeping antigen available for immune cells to display, independently of keeping pathogens alive, prevents that delay without allowing living pathogens to survive and evade control. The comparison is faster killing alone versus faster killing with preserved antigen, judged by the time needed for adaptive protection and whether living pathogens escape control. The broader motivation is restoring immune function in older people while retaining immune memory, avoiding attacks on the body's own tissues, and maintaining control of persistent infections; the supplied source does not establish those outcomes.
- Pathogen
- A disease-causing organism or infectious agent. The question does not specify which pathogen is involved.
- Innate immunity and innate killing
- Innate immunity is the body's early defense system; innate killing means its destruction of pathogens. Accelerating that killing is the proposed change, but the supplied material specifies no intervention that produces it.
- Adaptive immunity and adaptive protection
- Adaptive immunity is the learned, targeted part of immune defense. Adaptive protection here means its ability to protect against the pathogen; the supplied material does not define how that protection would be measured.
- Antigen and antigen availability
- Antigen is material recognized by the immune system. Availability refers here to how long that material remains accessible for recognition, rather than simply whether a pathogen is still alive.
- Presentable antigen and antigen presentation
- Presentable antigen is material that immune cells can display for recognition by other immune cells. Antigen presentation is that display process; preserving presentable material is not the same outcome as preserving living pathogens.
- Independent antigen preservation
- The proposed maintenance of presentable pathogen material separately from the survival of living pathogens. The supplied material does not specify a preservation method or establish that this separation succeeds.
- Viable-pathogen escape
- Survival and escape from control by pathogens that remain capable of sustaining infection. The question specifies no particular route of escape.
- Age-related immune dysfunction
- Immune functions that become impaired with age. This is the broader target of the question, but the supplied material gives no criteria for impairment or successful restoration.
- Immune memory
- Retention of learned immune recognition after an earlier encounter. Preserving protective memory is one constraint in the broader restoration goal.
- Self-tolerance
- Immune restraint toward the body's own tissues. The broader goal requires restored defense without losing that restraint.
- Latent infection
- An infection that persists in a relatively inactive state. Maintaining control of such infections is part of the broader goal, but is not examined by the supplied source.
- T cells and T cell activation
- T cells are immune cells involved in targeted immune responses; activation is their engagement in a response. S1 discusses activation in connection with attack on muscle, not demonstrated protection from infection.
- Inclusion body myositis
- The muscle disease examined in S1. The supplied abstract discusses immune attack on muscle in this setting, which differs from the pathogen-control setting of the question.
- Faster killing does not delay protection If faster killing does not shorten antigen availability enough to delay learned protection, the proposed reversal does not occur. Preserving antigen would then have no demonstrated delay to prevent under those conditions.
- Antigen preservation prevents delay without escape If faster killing reduces antigen availability and delays learned protection, preserving material that immune cells can display could prevent that delay. If living pathogens remain controlled, recognizable material and infectious survival would be separable in the way the question asks.
- Antigen preservation does not prevent delay If protection remains delayed despite preserving presentable antigen, preservation alone would not resolve the reversal. Faster early killing would still carry the observed timing cost under those conditions.
- Delay is prevented, but living pathogens escape If antigen preservation prevents the delay but living pathogens escape control, the combined outcome sought by the question is not achieved. Timely learned protection would coexist with failure to contain the infection.
The proposed chain starts with faster early killing, followed by a shorter supply of recognizable pathogen material, followed by delayed learned protection. If that chain occurs, an improvement in early pathogen removal could come with a later protection cost. If preserved antigen prevents the delay while living pathogens remain controlled, the proposed tradeoff could be avoided. Treating this possibility as established could wrongly equate longer antigen availability with better protection: the supplied source instead discusses sustained antigen presentation in an immune attack on muscle [S1].
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
After initial cognate priming and the first matched T–B interaction, loss of microbial viability signals, rather than loss of presentable antigen itself, causes the adaptive delay following accelerated killing. The strong hypothesis is that continued APC sensing of bacterial RNA can sustain already specified CD4-helper, CD8-effector and antibody-secreting-cell differentiation even after subsequent cognate antigen signaling is experimentally terminated. Independently preserving antigen therefore fails unless it also preserves the innate differentiation instruction; nonreplicating RNA stimulation can instead restore timely protection. The proposed causal substrate is the transient APC cytokine program maintained by microbial RNA.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
In older-donor cultures, first document cognate priming and matched T–B interaction, then terminate further antigen-receptor signaling using independently validated interventions. Non-antigen-encoding bacterial RNA delivered selectively to APCs restores the onset of antigen-specific target killing and functional antibody production despite absent subsequent cognate signaling. Matched antigen extension without RNA-dependent instruction does not restore both deadlines. Rescue confined to CD8 proliferation, nonspecific cytokine release or pre-existing antibody secretion falsifies the strong hypothesis.
Would tell it apart from at least one rival. The prediction specifies functional outcomes, a contrasting condition, and an explicit falsification condition. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
APC-targeted RNA delivery, timed antigen withdrawal, receptor-blocking controls and autologous functional cultures are available. Demonstrating effective termination of residual antigen signaling without injuring lymphocytes is the principal technical challenge. Track newly synthesized antibody and initially recruited clones separately from baseline memory output.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
In older-donor cultures, first document cognate priming and matched T–B interaction, then terminate further antigen-receptor signaling using independently validated interventions. Non-antigen-encoding bacterial RNA delivered selectively to APCs restores the onset of antigen-specific target killing and functional antibody production despite absent subsequent cognate signaling. Matched antigen extension without RNA-dependent instruction does not restore both deadlines. Rescue confined to CD8 proliferation, nonspecific cytokine release or pre-existing antibody secretion falsifies the strong hypothesis.
- Rival 01 of 02What would separate them
Rapid killing delays immune protection when cells cannot meet before antigen display ends predicts: With peptide identity, display amplitude, APC instruction and cell numbers matched, long or variable waits predict missed functional-response deadlines after rapid killing. Bringing cognate responders into contact earlier rescues cellular and humoral onset without antigen supplementation. Extending display preferentially recruits previously unprimed responders rather than accelerating differentiation of responders already primed. Failure of measured contact completion to predict rescue, together with rescue by RNA instruction or suppressor blockade at unchanged contact schedules, rejects this explanation.
- What would separate them
Clearing dead immune cells releases a signal that delays adaptive protection predicts: At matched peptide–MHC trajectories, microbial-RNA instruction and cognate-contact schedules, sterile conditioned medium collected during post-killing efferocytosis transfers the adaptive delay to independently primed cultures. Selectively interrupting recipient PGE2-receptor signaling removes that transfer and restores functional response onset without extending antigen display. Absence of increased efferocytosis/PGE2 after accelerated killing, or failure of pathway interruption to rescue despite verified target engagement, rejects the hypothesis.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
Live and killed bacteria can produce markedly different adaptive responses despite sharing conventional microbial patterns; bacterial RNA contributes to this difference. [Sander et al., 2011](https://www.nature.com/articles/nature10072). Human TLR8-dependent viability sensing can promote helper differentiation and vaccine responses. [Ugolini et al., 2018](https://pubmed.ncbi.nlm.nih.gov/29556002/). These observations support the candidate instruction channel, not the proposed dispensability of subsequent antigen signaling.
Adaptive differentiation and vaccine immunology: the textbook chapter 'T-cell-mediated immunity and B-cell activation' would require revision of the requirement for repeated cognate antigen encounters during helper-dependent response development. Initial specificity selection remains necessary.
Already specified older-adult lymphocytes achieve timely, target-specific cellular killing and newly generated functional antibody after subsequent cognate signaling is abolished, provided only that APC microbial-RNA instruction continues.
Targeted literature searches found support for microbial-RNA instruction and antigen-independent CD8 programming, but not for their strong conjunction: restoring helper-dependent functional antibody and cellular-response deadlines after experimentally terminating all subsequent cognate signaling. This is provisional novelty evidence, not proof that no review or perspective exists; the heretical designation remains conditional on a broader novelty audit.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. 6 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: Dimethyl Sulfoxide Modulates T Cell-Mediated Immunity to Attenuate Influenza A Virus Infection.; Innate immune activation profiles are associated with polarization of the T cell response to recombinant arenaviral vectors.; FOXP1 Knockdown Reprograms Th9 CAR-T Cells to Overcome Antigen Escape..
6 papers retrieved around this hypothesis
- Enrichment of CD4<sup>-</sup>CD8<sup>-</sup> cytotoxic Vδ1/3 T cells in pulmonary tuberculosis disease.PMID 42662901 · full_text · 78,187 characters stored
- Anti-CD6 monoclonal antibody UMCD6 induces CD6 internalization, remodels costimulatory receptor availability, and modulates CD4<sup>+</sup> T-cell activation.PMID 42688261 · full_text · 82,435 characters stored
- Innate immune activation profiles are associated with polarization of the T cell response to recombinant arenaviral vectors.PMID 42755684 · full_text · 86,184 characters stored
- FOXP1 Knockdown Reprograms Th9 CAR-T Cells to Overcome Antigen Escape.PMID 42750117 · full_text · 83,271 characters stored
- Dimethyl Sulfoxide Modulates T Cell-Mediated Immunity to Attenuate Influenza A Virus Infection.PMID 42763701 · full_text · 58,354 characters stored
- Nonpathogenic SIV Infection in Sooty Mangabeys Is Characterized by a Lack of Activation and Expansion of Monocytes.PMID 42596509 · full_text · 60,714 characters stored
0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 6 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.